Independent Pharmacies Must Expand Services to Stay Afloat | AAP 2025
Drug Topics
APRIL 16, 2025
At AAP 2025, Douglas Hoey, RPh, MBA, CEO of NCPA, discussed what pharmacies can do to increase revenue and avoid shutting their doors.
Wed.Apr 16, 2025
465 
Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub
PharmaVoice
APRIL 16, 2025
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Approves Diazepam Nasal Spray for Treatment of Seizure Clusters in Pediatric Patients
Drug Topics
APRIL 16, 2025
The drug is approved for the short-term treatment of acute repetitive seizures, also known as seizure clusters, which differ from a patients normal seizure pattern.
Pharmacy Student Study Strategies To Maximizing Learning In 2025 And Beyond
IDStewardship
APRIL 16, 2025
In this article a current third year pharmacy student discusses pharmacy student study strategies to maximize learning in 2025 and beyond. Authored By:Fabian Quiroga, Pharm.D. Candidate 2026 Article posted 16 April 2025 No one really warns you about just how much content you will encounterin pharmacy school – until you are in it. Whether it is a single week, an entire module, or the full school year, the amount of material can feel overwhelming.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Skin of Color Dermatology Substantially Improved in Last 20 Years
Drug Topics
APRIL 16, 2025
Over 20 years since skin of color dermatology was introduced, researchers explored advancements and what is yet to come in the future.
5 Things To Know About Interpreting MRSA Nares Swab Results
IDStewardship
APRIL 16, 2025
In this article two infectious diseases pharmacists discuss five things to know about interpreting MRSA naresswab results Authored By: Hunter Rondeau, Pharm.D., BCIDP & Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 The methicillin-resistant Staphylococcus aureus (MRSA) naresswab (also referred to as a MRSA nasal swab) is a valuable tool for infection control programs, helping to identify which patients are colonized with MRSA and in turn may be at risk for MRSA inf
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Five Tidbits From The Largest International Meeting Of Clinical Microbiologists & Infectious Diseases Specialists In 2025
IDStewardship
APRIL 16, 2025
In this article an infectious diseases pharmacist discusses someof many learning tidbitsfrom ESCMID Global 2025, the largest international meeting of clinical microbiologists and infectious diseases specialists. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 This year the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) held their main annual conference called ESCMID Global in Vienna, Austria.
Pharmacist Counseling ‘Paramount’ in Use of OTC Pain Medications
Drug Topics
APRIL 16, 2025
Pain expert Mark Garofoli, PharmD, BCGP, CPE, CTTS, discussed the pharmacists role in managing patients use of OTC pain relief products.
Opinion: The CDC’s critical occupational safety institute has been virtually wiped out
STAT
APRIL 16, 2025
In a single day, 10,000 federal workers at the Centers for Disease Control and Prevention and the Food and Drug Administration were laid off, including 90% or more of those at the CDC’s National Institute for Occupational Safety and Health (NIOSH). The office may be little-known outside of public health circles, but it is of critical importance.
What is Data-Driven Marketing in Pharma
Pharma Marketing Network
APRIL 16, 2025
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Salvation Army faces class-action suit over denying addiction medications
STAT
APRIL 16, 2025
A federal judge has given the go-ahead for a class-action lawsuit that could radically expand Americans’ access to lifesaving addiction medications. The perhaps surprising defendant: The Salvation Army, the Christian charity known more for its thrift stores than for its nationwide network of addiction treatment facilities.
COVID-19 Associated With Higher Risk of Postacute Kidney Outcomes in Pediatric Patients With Preexisting CKD
Pharmacy Times
APRIL 16, 2025
At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.
Opinion: STAT+: Promising signs for stem cell-based therapies for Parkinson’s in two new studies
STAT
APRIL 16, 2025
Welcome to Lab Dish , a new First Opinion column on regenerative medicine from Paul Knoepfler. I’m upbeat about cell therapy development for Parkinson’s disease, but it has been a marathon. Now two new clinical trial papers published Wednesday in Nature on stem cell-based therapies for Parkinson’s are another step forward. However, they also highlight remaining challenges and dilemmas, including the optimal doses of cells, the extent of engraftment, and whether to use alloge
Diazepam Nasal Spray Receives FDA Approval for Seizure Clusters in Individuals 2 Years and Older
Pharmacy Times
APRIL 16, 2025
The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Device maker that helped UnitedHealth collect billions offers to settle fraud claims with DOJ
STAT
APRIL 16, 2025
Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal health care fraud claims related to its peripheral artery disease test, QuantaFlo — a product used by UnitedHealth Group and other large insurers. Semler revealed the preliminary agreement in an SEC filing Tuesday, but noted the government could still reject the offer.
Content Marketing Strategies Used in Pharma Marketing
Pharma Marketing Network
APRIL 16, 2025
If your brand still views content as a checkbox for SEO or a static digital asset, you’re already falling behind. In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. But not just any content will do. Today, successful campaigns are dynamic, identity-driven, omnichannel, and personalized.
WHO member countries agree on a draft ‘pandemic treaty’ to try to avoid Covid-19 mistakes
STAT
APRIL 16, 2025
LONDON — Five years after Covid-19 triggered national lockdowns, economic uncertainty and killed millions , the World Health Organization’s member countries agreed on a draft “pandemic treaty” that sets guidelines for how the international community might confront the next global health crisis.
More Than Just Meds: What a Palliative Care Pharmacist Learned From the Bedside
Pharmacy Times
APRIL 16, 2025
A palliative care pharmacist highlights a spectrum of clinical opportunities for patients, caregivers, and clinicians when rounding at the bedside.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Enforcement Under the New FDA: HPM to Host a Q&A Webinar on FDC Act Enforcement with Three Former Federal Prosecutors
The FDA Law Blog
APRIL 16, 2025
By Andrew J. Hull & JP Ellison & John W.M. Claud Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. (ET) (register here ). Join us as HPMs Anne Walsh moderates a panel discussion with three former DOJ attorneys who all litigated extensively under the FDCA.
Streamlining JCA Response with GenAI
pharmaphorum
APRIL 16, 2025
The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.
Johnson & Johnson announces successful results from trial for myeloma treatment
Pharmafile
APRIL 16, 2025
Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) rates of newly diagnosed multiple myeloma (NDMM) than conventional bortezomib, lenalidomide and dexamethasone (VRd) chemotherapy. The treatment could help NDMM patients approach normal expectancy without their disease progressing, with PFS projected to be 17 years. […] The post Johnson & Johnson announces successful
FDA clears first migraine DTx from Click Therapeutics
pharmaphorum
APRIL 16, 2025
Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.
Astraveus expands leadership team ahead of Lakhesys launch
Pharmafile
APRIL 16, 2025
Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, an innovative microfluidic system for cell therapy manufacturing. Jean-Paul Mangeolle (pictured left) joins as chairman of the board of directors, bringing more than 35 years of life sciences leadership, including leadership roles at Millipore, Danaher […] The post Astraveus expands leadership team ahead of Lakhesys launch appeared first on Pharmafile.
European Commission Alzheimer’s drug approval marks advancement for EU patients
European Pharmaceutical Review
APRIL 16, 2025
The European Commission (EC) has granted a marketing authorization for Leqembi (lecanemab) as the first therapy in the EU targeting an underlying cause of Alzheimers. Eisai Co., Ltd. and Biogen Inc.s amyloid-beta (A) monoclonal antibody is indicated for adults with mild cognitive impairment and mild dementia due to Alzheimers who are apolipoprotein E 4 (ApoE 4*) non-carriers or heterozygotes with confirmed amyloid pathology.
STAT+: NEJM AI’s editor-in-chief on FDA approval vs. clinical effectiveness
STAT
APRIL 16, 2025
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Isaac “Zak” Kohane is the chair of biomedical informatics at Harvard Medical School. He’s uniquely situated for the explosion of AI in health care, having a Ph.D. in computer science as well as an M.D.
The Tech Truth: Stepping Up as Pharmacy Technician Leaders
Pharmacy Times
APRIL 16, 2025
Pharmacy technicians have a pivotal opportunity to advance professionally by proactively demonstrating leadership, offering solutions, and clearly communicating their value to health care leaders.
UK Biobank responds to fears over Chinese access to NHS data
pharmaphorum
APRIL 16, 2025
Access to de-identified NHS patient data by researchers based in China is not a security concern, according to UK Biobank.
Five Domains, One Outcome: How Social Factors Shape Cancer Survival
Pharmacy Times
APRIL 16, 2025
Iman Ahmed, PharmD, BCOP shared key insights about how social determinants of health impact treatment access and outcomes for patients with leukemia.
WHO member states agree on treaty to fight future pandemics
Pharmaceutical Technology
APRIL 16, 2025
The agreement is seen as a win for global health ahead of the US withdrawal from the WHO and amidst foreign aid cuts by the US government.
APA, NCPA Cheer First-Of-Its-Kind State Law Banning PBMs from Owning Pharmacies
Pharmacy Times
APRIL 16, 2025
Arkansas HB 1150 a model for other states, federal government, organizations say.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
VC firm SignalFire closed on $1 billion in new capital to fund applied AI companies; a handful of health systems backed Hellocare.ai's funding round and Layer Health picked up $21 million in series A funding to scale its AI-powered platform.
Inhaled siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients With Mild COVID-19
Pharmacy Times
APRIL 16, 2025
With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
The deal for Cedar Park Regional Medical Center and other ancillary businesses is expected to close this summer. Ascension Seton already held a minority interest in the hospital, and said that sole ownership will allow for service expansions.
Let's personalize your content